A detailed history of Evernest Financial Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Evernest Financial Advisors, LLC holds 2,663 shares of AMGN stock, worth $782,922. This represents 0.24% of its overall portfolio holdings.

Number of Shares
2,663
Previous 2,564 3.86%
Holding current value
$782,922
Previous $801,000 7.12%
% of portfolio
0.24%
Previous 0.37%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$309.38 - $337.38 $30,628 - $33,400
99 Added 3.86%
2,663 $858,000
Q2 2024

Aug 07, 2024

SELL
$262.75 - $319.31 $40,463 - $49,173
-154 Reduced 5.67%
2,564 $801,000
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $21,509 - $25,964
80 Added 3.03%
2,718 $731 Million
Q4 2023

May 10, 2024

SELL
$255.7 - $288.46 $27,104 - $30,576
-106 Reduced 3.9%
2,612 $752 Million
Q4 2021

Feb 13, 2024

BUY
$198.88 - $227.6 $524,645 - $600,408
2,638 New
2,638 $768 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Evernest Financial Advisors, LLC Portfolio

Follow Evernest Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evernest Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evernest Financial Advisors, LLC with notifications on news.